[Photo] 'For a World Without Corona...'
![[Photo] 'For a World Without Corona...'](http://www.asiae.co.kr/news/img_view.htm?img=2020122216082480213_1608620904.jpg)
Countries around the world are racing to develop vaccines and treatments to overcome the novel coronavirus infection (COVID-19). The domestic bio venture company, Engicam Life Sciences, has received approval for a new drug substance from the U.S. Food and Drug Administration (FDA) and is conducting Phase 2 clinical trials. Ahead of the new year 2021, a researcher is fully engaged in COVID-19 treatment research at Engicam Life Sciences Central Research Institute in Jecheon, Chungbuk./Reporter Kang Jin-hyung aymsdream@
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051414165763158_1778735817.jpg)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- [Breaking] Park Sukeun, Central Labor Relations Commission Chair: "Some Gaps Narrowed Between Samsung Electronics Labor and Management"
- Is This the Peak? As Others Hesitate..."The Answer Is Clear for Surviving the KOSPI 10,000 Era"
- Oil and Bond Markets Breathe Easier as Ceasefire Talks Resume... Inflation Remains a Ticking Time Bomb
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
